Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades
10:45am, Friday, 25'th Oct 2024
Investors should monitor stocks like AAL, ACDVF, EBS, BRY and CBRL for high returns.
GREENBELT, Md., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the District of Maryland has approved the following announcement of a proposed class
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
07:30am, Wednesday, 23'rd Oct 2024
GAITHERSBURG, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, November 6, 2024, at 5:00 pm eastern time to discuss the finan
GAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread opioid emergency preparedness by expanding access to NARCAN® Nas
Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario
09:48am, Friday, 04'th Oct 2024
Emergent BioSolutions is showing signs of a potential turnaround with strategic restructuring, cost-cutting, and securing significant contracts in public health preparedness. Despite a challenging Q2,
GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatme
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
10:33am, Wednesday, 25'th Sep 2024
On Wednesday, Emergent BioSolutions Inc. EBS said it secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox, and mpox product portfolio.
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
07:07am, Wednesday, 25'th Sep 2024
$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025 $185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025
Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
06:45am, Friday, 13'th Sep 2024
GAITHERSBURG, Md., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent” or the “Company”) today announced that it has entered into an agreement to resolve the
GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a contract modification executing an option period by the Biomedical
OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing
05:51pm, Wednesday, 04'th Sep 2024
New York, New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and sole lender of a $250 million term loan facility supporting Emergent BioSolution
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
07:08am, Tuesday, 03'rd Sep 2024
New favorable terms position Emergent for sustainable, long-term growth, as part of its multi-year plan to stabilize, turnaround and transform the company New favorable terms position Emergent for sus
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz
06:45pm, Friday, 30'th Aug 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk opportunities in pharma investing following approval of Emergent Bio's Mpox vaccine.
EBS Stock Rises on FDA Nod for ACAM2000 in Mpox Indication
12:41pm, Friday, 30'th Aug 2024
The FDA approves Emergent BioSolutions' sBLA seeking a label expansion of ACAM2000 for the mpox indication. Stock rises in pre-market trading.
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
08:16am, Friday, 30'th Aug 2024
GAITHERSBURG, Md., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is kicking off the second year of the Ready to Rescue initiative, which will include n
